ESSA Pharma Inc.

NASDAQ: EPIX · Real-Time Price · USD
1.93
0.01 (0.52%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.00%
After-hours: Aug 15, 2025, 06:42 PM EDT

ESSA Pharma Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 118.49K 121.79K 109.46K
Gross Profit
n/a -118.49K -121.79K -109.46K
Operating Income
-34.42M -32.13M -35.34M -36.91M
Interest Income
n/a 5.55M 1.74M 235K
Pretax Income
-28.54M -26.58M -35.22M -36.84M
Net Income
-28.54M -26.58M -35.1M -36.81M
Selling & General & Admin
n/a 10.81M 12.54M 12.78M
Research & Development
21.21M 21.32M 24.41M 24.26M
Other Expenses
n/a n/a n/a 109.46K
Operating Expenses
21.21M 32.13M 36.96M 37.14M
Interest Expense
n/a 6.94K 14K 22.22K
Selling & Marketing Expenses
n/a 22.57K n/a n/a
Cost & Expenses
n/a 32.13M 36.96M 37.14M
Income Tax Expense
n/a 1.6K -112K -34.35K
Shares Outstanding (Basic)
44.28M 44.09M 44.04M 38.48M
Shares Outstanding (Diluted)
44.28M 44.09M 44.04M 38.48M
EPS (Basic)
-0.64 -0.6 -0.8 -0.96
EPS (Diluted)
-0.64 -0.6 -0.8 -0.96
EBITDA
-28.45M -26.46M -35.08M -36.71M
EBIT
n/a -26.57M -35.2M -36.82M
Depreciation & Amortization
n/a 118.49K 121.79K 109.46K